{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T14:58:00Z","timestamp":1787497080735,"version":"build-2736575974"},"reference-count":69,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2004,8,1]],"date-time":"2004-08-01T00:00:00Z","timestamp":1091318400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The American Journal of Medicine Supplements"],"published-print":{"date-parts":[[2004,8]]},"DOI":"10.1016\/j.amjmed.2004.07.007","type":"journal-article","created":{"date-parts":[[2004,9,24]],"date-time":"2004-09-24T11:56:47Z","timestamp":1096027007000},"page":"39-50","source":"Crossref","is-referenced-by-count":22,"special_numbering":"S1","title":["Streptococcus pneumoniae and community-acquired pneumonia: A cause for concern"],"prefix":"10.1016","volume":"117","author":[{"suffix":"Jr.","given":"Thomas M","family":"File","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjmed.2004.07.007_BIB1","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1016\/S0140-6736(03)15021-0","article-title":"Community-acquired pneumonia","volume":"362","author":"File","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.amjmed.2004.07.007_BIB2","unstructured":"Murphy SL. Deaths: Final Data for 1998. Hyattsville, MD: US Dept of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics; 2000. National Vital Statistics Reports, Volume 48, No. 11. DHHS publication no. PHS 2000-1120"},{"key":"10.1016\/j.amjmed.2004.07.007_BIB3","first-page":"556","article-title":"Premature deaths, monthly mortality, and monthly physician contacts","volume":"46","year":"1997","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.amjmed.2004.07.007_BIB4","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1001\/archinte.157.15.1709","article-title":"Incidence of community-acquired pneumonia requiring hospitalization","volume":"157","author":"Marston","year":"1997","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.amjmed.2004.07.007_BIB5","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1056\/NEJM199701233360402","article-title":"A prediction rule to identify low-risk patients with community-acquired pneumonia","volume":"336","author":"Fine","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjmed.2004.07.007_BIB6","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1001\/jama.1996.03530260048030","article-title":"Prognosis and outcomes of patients with community-acquired pneumonia","volume":"275","author":"Fine","year":"1996","journal-title":"JAMA"},{"key":"10.1016\/j.amjmed.2004.07.007_BIB7","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1086\/313954","article-title":"Guidelines from the Infectious Diseases Society of America","volume":"31","author":"Bartlett","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.amjmed.2004.07.007_BIB8","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/S0149-2918(98)80144-6","article-title":"The cost of treating community-acquired pneumonia","volume":"20","author":"Niederman","year":"1998","journal-title":"Clin Ther"},{"key":"10.1016\/j.amjmed.2004.07.007_BIB9","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1001\/archinte.161.22.2725","article-title":"Economic burden of pneumonia in an employed population","volume":"161","author":"Birnbaum","year":"2001","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.amjmed.2004.07.007_BIB10","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1080\/00365549850160882","article-title":"Pneumonia caused by penicillin-non-susceptible and penicillin-susceptible pneumococci in adults","volume":"30","author":"Einarsson","year":"1998","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.amjmed.2004.07.007_BIB11","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1001\/jama.1996.03530270034028","article-title":"Bacteremia with Streptococcus pneumoniae","volume":"275","author":"Plouffe","year":"1996","journal-title":"JAMA"},{"key":"10.1016\/j.amjmed.2004.07.007_BIB12","doi-asserted-by":"crossref","first-page":"223","DOI":"10.2105\/AJPH.90.2.223","article-title":"Mortality from invasive pneumococcal pneumonia in the era of antibiotic resistance, 1995-1997","volume":"90","author":"Feikin","year":"2000","journal-title":"Am J Public Health"},{"key":"10.1016\/j.amjmed.2004.07.007_BIB13","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1086\/520209","article-title":"Penicillin resistance and other predictors of mortality in pneumococcal bacteremia in a population with high human immunodeficiency virus seroprevalence","volume":"29","author":"Turett","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.amjmed.2004.07.007_BIB14","unstructured":"Battleman D, Oppenheim M, Zuccotti G, Ruchlin H, Teutsch S, Callahan M. Clinical and economic consequences of bacterial resistance in community-acquired pneumococcal pneumonia. Presented at the 41st Interscience Conference on Antimicrobial Agents and Chemotherapy; September 22\u201325, 2001; Chicago, IL. Abstract O-393"},{"key":"10.1016\/j.amjmed.2004.07.007_BIB15","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/00005792-200103000-00001","article-title":"Community-acquired pneumonia","volume":"80","author":"Bochud","year":"2001","journal-title":"Medicine"},{"key":"10.1016\/j.amjmed.2004.07.007_BIB16","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1378\/chest.118.5.1344","article-title":"Community-acquired pneumonia","volume":"118","author":"Luna","year":"2000","journal-title":"Chest"},{"key":"10.1016\/j.amjmed.2004.07.007_BIB17","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0002-9343(99)00050-9","article-title":"Is Streptococcus pneumoniae the leading cause of pneumonia of unknown etiology? A microbiologic study of lung aspirates in consecutive patients with community-acquired pneumonia","volume":"106","author":"Ruiz-Gonz\u00e1lez","year":"1999","journal-title":"Am J Med"},{"key":"10.1016\/j.amjmed.2004.07.007_BIB18","series-title":"The American Journal of Medicine Continuing Education Series. New Challenges in Respiratory Tract Infection and Causative Pathogen\u2014Part 1","first-page":"3","article-title":"The etiology and impact of community-acquired pneumonia","author":"File","year":"1997"},{"key":"10.1016\/j.amjmed.2004.07.007_BIB19","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1086\/380488","article-title":"Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults","volume":"37","author":"Mandell","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.amjmed.2004.07.007_BIB20","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1056\/NEJM199512143332408","article-title":"Community-acquired pneumonia","volume":"333","author":"Bartlett","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjmed.2004.07.007_BIB21","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1001\/archinte.161.15.1866","article-title":"Nonsevere community-acquired pneumonia","volume":"161","author":"Falguera","year":"2001","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.amjmed.2004.07.007_BIB22","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1164\/ajrccm.154.5.8912764","article-title":"Community-acquired pneumonia in chronic obstructive pulmonary disease","volume":"154","author":"Torres","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.amjmed.2004.07.007_BIB23","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1378\/chest.122.4.1118","article-title":"COPD exacerbations","volume":"122","author":"Dewan","year":"2002","journal-title":"Chest"},{"key":"10.1016\/j.amjmed.2004.07.007_BIB24","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1378\/chest.122.4.1264","article-title":"Pneumonic versus nonpneumonic acute exacerbations of COPD","volume":"122","author":"Lieberman","year":"2002","journal-title":"Chest"},{"key":"10.1016\/j.amjmed.2004.07.007_BIB25","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1164\/ajrccm.163.7.at1010","article-title":"Guidelines for the management of adults with community-acquired pneumonia","volume":"163","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.amjmed.2004.07.007_BIB26","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1086\/520286","article-title":"Drug-resistant Streptococcus pneumoniae","volume":"26","author":"Campbell","year":"1998","journal-title":"Clin Infect Dis"},{"issue":"suppl 1","key":"10.1016\/j.amjmed.2004.07.007_BIB27","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1086\/324526","article-title":"Appropriate use of antimicrobials for drug-resistant pneumonia","volume":"34","author":"File","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.amjmed.2004.07.007_BIB28","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1093\/jac\/dkg321","article-title":"The Alexander Project 1998\u20132000","volume":"52","author":"Jacobs","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.amjmed.2004.07.007_BIB29","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1093\/clinids\/15.1.77","article-title":"Antimicrobial resistance in Streptococcus pneumoniae","volume":"15","author":"Appelbaum","year":"1992","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.amjmed.2004.07.007_BIB30","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1128\/AAC.40.5.1208","article-title":"Antimicrobial resistance of Streptococcus pneumoniae recovered from outpatients in the United States during the winter months of 1994 to 1995","volume":"40","author":"Doern","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.amjmed.2004.07.007_BIB31","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1128\/AAC.45.6.1721-1729.2001","article-title":"Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in the United States during 1999\u20132000, including a comparison of resistance rates since 1994\u20131995","volume":"45","author":"Doern","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.amjmed.2004.07.007_BIB32","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1093\/clinids\/22.1.63","article-title":"Epidemiological features of and risk factors for infection by Streptococcus pneumoniae strains with diminished susceptibility to penicillin","volume":"22","author":"B\u00e9dos","year":"1996","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.amjmed.2004.07.007_BIB33","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1093\/clinids\/15.1.84","article-title":"Antimicrobial resistance in Streptococcus pneumoniae","volume":"15","author":"Koornhof","year":"1992","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.amjmed.2004.07.007_BIB34","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1093\/clinids\/15.1.99","article-title":"Trends in antimicrobial resistance of clinical isolates of Streptococcus pneumoniae in Bellvitge Hospital, Barcelona, Spain (1979\u20131990)","volume":"15","author":"Li\u00f1ares","year":"1992","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.amjmed.2004.07.007_BIB35","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1093\/clinids\/15.1.106","article-title":"Pneumococcal antimicrobial resistance","volume":"15","author":"Marton","year":"1992","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.amjmed.2004.07.007_BIB36","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1093\/jac\/45.4.457","article-title":"Resistance surveillance of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis isolated in Asia and Europe, 1997-1998","volume":"45","author":"Sahm","year":"2000","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.amjmed.2004.07.007_BIB37","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1093\/infdis\/168.1.158","article-title":"Evidence for the introduction of a multiresistant clone of serotype 6B Streptococcus pneumoniae from Spain to Iceland in the late 1980s","volume":"168","author":"Soares","year":"1993","journal-title":"J Infect Dis"},{"key":"10.1016\/j.amjmed.2004.07.007_BIB38","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1128\/AAC.43.10.2504","article-title":"Prevalence of antimicrobial resistance in respiratory tract isolates of Streptococcus pneumoniae","volume":"43","author":"Zhanel","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.amjmed.2004.07.007_BIB39","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1086\/313976","article-title":"Bacteremic pneumonia due to multidrug-resistant pneumococci in 3 patients treated unsuccessfully with azithromycin and successfully with levofloxacin","volume":"31","author":"Fogarty","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.amjmed.2004.07.007_BIB40","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1086\/318157","article-title":"Breakthrough pneumococcal bacteremia in patients being treated with azithromycin and clarithromycin","volume":"31","author":"Kelley","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.amjmed.2004.07.007_BIB41","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1056\/NEJM200202213460820","article-title":"Emergence of macrolide resistance during treatment of pneumococcal pneumonia [letter]","volume":"346","author":"Musher","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjmed.2004.07.007_BIB42","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1378\/chest.118.6.1839-a","article-title":"Fatal pneumococcal pneumonia attributed to macrolide resistance and azithromycin monotherapy [letter]","volume":"118","author":"Waterer","year":"2000","journal-title":"Chest"},{"key":"10.1016\/j.amjmed.2004.07.007_BIB43","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1056\/NEJM200012283432603","volume":"343","author":"Whitney","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjmed.2004.07.007_BIB44","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1056\/NEJM199907223410403","article-title":"Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada","volume":"341","author":"Chen","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjmed.2004.07.007_BIB45","unstructured":"Tang P, Green K, McGeer A, et al. Emerging resistance in respiratory tract isolates of Streptococcus pneumoniae (SP) in Canada. Presented at the 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy; September 27\u201330, 2002; San Diego, CA. Abstract L-992"},{"key":"10.1016\/j.amjmed.2004.07.007_BIB46","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1128\/AAC.43.5.1310","article-title":"Emergence of fluoroquinolone resistance among multiply resistant strains of Streptococcus pneumoniae in Hong Kong","volume":"43","author":"Ho","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.amjmed.2004.07.007_BIB47","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1086\/376642","article-title":"Emergence of levofloxacin-resistant pneumococci in immunocompromised adults after therapy for community-acquired pneumonia","volume":"37","author":"Anderson","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.amjmed.2004.07.007_BIB48","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1056\/NEJMoa012122","article-title":"Resistance to levofloxacin and failure of treatment of pneumococcal pneumonia","volume":"346","author":"Davidson","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjmed.2004.07.007_BIB49","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1345\/aph.10229","article-title":"Levofloxacin failure in a patient with pneumococcal pneumonia","volume":"35","author":"Empey","year":"2001","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.amjmed.2004.07.007_BIB50","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1086\/319222","article-title":"Risk factors for acquisition of levofloxacin-resistant Streptococcus pneumoniae","volume":"32","author":"Ho","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.amjmed.2004.07.007_BIB51","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1592\/phco.22.5.395.33185","article-title":"Levofloxacin treatment failure in a patient with fluoroquinolone-resistant Streptococcus pneumoniae pneumonia","volume":"22","author":"Kays","year":"2002","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.amjmed.2004.07.007_BIB52","doi-asserted-by":"crossref","first-page":"312","DOI":"10.7326\/0003-4819-131-4-199908170-00023","article-title":"Fluoroquinolone resistance in Streptococcus pneumoniae [letter]","volume":"131","author":"Kuehnert","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.amjmed.2004.07.007_BIB53","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1056\/NEJM200207043470115","article-title":"Resistance to levofloxacin and failure of treatment of pneumococcal pneumonia [letter]","volume":"347","author":"Ross","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjmed.2004.07.007_BIB54","first-page":"929","article-title":"Increasing prevalence of drug-resistant S pneumoniae (DRSP)","volume":"27","author":"Whitney","year":"1998","journal-title":"Clin Infect Dis"},{"issue":"suppl C","key":"10.1016\/j.amjmed.2004.07.007_BIB55","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1093\/jac\/28.suppl_C.31","article-title":"A review of antibiotic resistance patterns of Streptococcus pneumoniae in Europe","volume":"28","author":"Baquero","year":"1991","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.amjmed.2004.07.007_BIB56","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1001\/jama.286.15.1857","volume":"286","author":"Hyde","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.amjmed.2004.07.007_BIB57","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1086\/374556","article-title":"Streptococcus pneumoniae bacteremia","volume":"36","author":"Ruhe","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.amjmed.2004.07.007_BIB58","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1001\/jama.279.5.365","article-title":"Low dosage and long treatment duration of \u03b2-lactam","volume":"279","author":"Guillemot","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.amjmed.2004.07.007_BIB59","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1086\/377534","article-title":"An international prospective study of pneumococcal bacteremia","volume":"37","author":"Yu","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.amjmed.2004.07.007_BIB60","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1086\/338065","article-title":"The molecular epidemiology of penicillin-resistant Streptococcus pneumoniae in the United States, 1994-2000","volume":"34","author":"Richter","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.amjmed.2004.07.007_BIB61","unstructured":"National Committee for Clinical Laboratory Standards. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically: Approved Standard. 5th ed. Wayne, PA: NCCLS; 2000:17(2). NCCLS document M7-A5"},{"key":"10.1016\/j.amjmed.2004.07.007_BIB62","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1086\/313716","article-title":"Impact of penicillin susceptibility on medical outcomes for adult patients with bacteremic pneumococcal pneumonia","volume":"30","author":"Metlay","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.amjmed.2004.07.007_BIB63","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1056\/NEJM199508243330802","article-title":"Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain","volume":"333","author":"Pallares","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjmed.2004.07.007_BIB64","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1086\/322623","article-title":"Clinical outcomes of bacteremic pneumococcal pneumonia in the era of antibiotic resistance","volume":"33","author":"Moroney","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.amjmed.2004.07.007_BIB65","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1001\/archinte.160.10.1399","article-title":"Management of community-acquired pneumonia in the era of pneumococcal resistance","volume":"160","author":"Heffelfinger","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.amjmed.2004.07.007_BIB66","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0924-8579(02)00126-7","article-title":"The efficacy and safety of oral pharmacokinetically enhanced amoxycillin-clavulanate 2000\/125 mg, twice daily, versus oral amoxycillin-clavulanate 1000\/125 mg, three times daily, for the treatment of bacterial community-acquired pneumonia in adults","volume":"20","author":"Petitpretz","year":"2002","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.amjmed.2004.07.007_BIB67","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/S0149-2918(01)80061-8","article-title":"The clinical pharmacokinetics of a new pharmacokinetically enhanced formulation of amoxicillin\/clavulanate","volume":"23","author":"Kaye","year":"2001","journal-title":"Clin Ther"},{"key":"10.1016\/j.amjmed.2004.07.007_BIB68","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0924-8579(02)00130-9","article-title":"Outcome of treatment of respiratory tract infections due to Streptococcus pneumoniae, including drug-resistant strains, with pharmacokinetically enhanced amoxycillin\/clavulanate","volume":"20","author":"File","year":"2002","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.amjmed.2004.07.007_BIB69","first-page":"713","article-title":"Rational use of antibiotics to treat respiratory tract infections","volume":"8","author":"File","year":"2002","journal-title":"Am J Manag Care"}],"container-title":["The American Journal of Medicine Supplements"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S154827660400007X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S154827660400007X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,3]],"date-time":"2020-04-03T01:51:12Z","timestamp":1585878672000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S154827660400007X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,8]]},"references-count":69,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2004,8]]}},"alternative-id":["S154827660400007X"],"URL":"https:\/\/doi.org\/10.1016\/j.amjmed.2004.07.007","relation":{},"ISSN":["1548-2766"],"issn-type":[{"value":"1548-2766","type":"print"}],"subject":[],"published":{"date-parts":[[2004,8]]}}}